Chemoinformaics analysis of (+)-S-(1-propenyl)-L-cysteine sulfoxide (PRENCSO)
Molecular Weight | 177.225 | nRot | 4 |
Heavy Atom Molecular Weight | 166.137 | nRig | 2 |
Exact Molecular Weight | 177.046 | nRing | 0 |
Solubility: LogS | -0.173 | nHRing | 0 |
Solubility: LogP | -2.374 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 23.7607 |
nHD | 1 | BPOL | 16.1893 |
QED | 0.522 |
Synth | 5.847 |
Natural Product Likeliness | 0.447 |
NR-PPAR-gamma | 0.02 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.109 |
HIA | 0.078 |
CACO-2 | -5.325 |
MDCK | 0.00308684 |
BBB | 0.649 |
PPB | 0.0733145 |
VDSS | 0.615 |
FU | 0.903403 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.059 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.06 |
CYP2c9-inh | 0.016 |
CYP2c9-sub | 0.669 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.161 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.016 |
CL | 2.265 |
T12 | 0.895 |
hERG | 0.008 |
Ames | 0.669 |
ROA | 0.416 |
SkinSen | 0.474 |
Carcinogencity | 0.682 |
EI | 0.093 |
Respiratory | 0.477 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.919566 |